Company intelligence / Profile preview

Genapsys

Redwood City, California, United States

Ownership: Private
Employees: ~165
Development stage: Other

Overview

Genapsys has developed and is commercializing an electronic, microfluidic-based DNA sequencing platform (GENIUS), designed to be affordable, scalable, and accurate, primarily for research use in genomic testing[1][2][3][4][5][6][7]. There is no evidence of therapeutics or clinical trial results, as products are for research use only, not for diagnostics.

Modalities: Device
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Genapsys.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genapsys.

Explore the full profile